You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

donor chimerism,

Showing 1 - 25 of 3,438
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Predict T Cell Chimerism After MSD SCT for SCD?

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab Injection [Campath]
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jun 20, 2023

Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

Recruiting
  • Myeloid Chimerism
  • CliniMACS CD34 Reagent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Response Rate Trial in Shanghai (Decitabine)

Completed
  • Response Rate
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 19, 2021

Cell-Free Nucleic Acids Trial (Cell free DNA analysis)

Not yet recruiting
  • Cell-Free Nucleic Acids
  • Cell free DNA analysis
  • (no location specified)
Jan 27, 2022

Sickle Cell Disease, Beta Thalassemia Trial in New York (Busulfan, Fludarabine, Alemtuzumab)

Active, not recruiting
  • Sickle Cell Disease
  • Beta Thalassemia
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
Aug 12, 2021

Kidney Transplant Rejection Trial (MDR-103)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-103
  • (no location specified)
Apr 4, 2022

Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem

Recruiting
  • Graft-versus-host Disease
  • +2 more
  • Mesenchymal stem cells
  • Edeghem, Antwerpen, Belgium
  • +11 more
Sep 19, 2022

Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

Active, not recruiting
  • Renal Failure
  • Enriched Hematopoietic Stem Cell Infusion
  • Chicago, Illinois
  • +1 more
Jul 15, 2022

MDS, Leukemia, Myeloid, Acute Trial in London (DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell

Unknown status
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
  • DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell transplant regardless of peripheral blood CD3 chimerism (including if they have full donor chimerism)
  • DLI will be administered from Month 6 (+/- 20 days) after stem cell transplant according to institutional practice
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 1, 2020

Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

Completed
Has Results
  • Hemophagocytic Lymphohistiocytosis
  • +5 more
  • Hematopoietic Stem Cell Transplant
  • Birmingham, Alabama
  • +21 more
Dec 6, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

    Active, not recruiting
    • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    Myeloid Malignancy Trial in Detroit (azacitidine)

    Recruiting
    • Myeloid Malignancy
    • Detroit, Michigan
      Henry ford hospital
    Dec 23, 2021

    Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)

    Not yet recruiting
    • Kidney Failure
    • +2 more
    • Bone Marrow Transplant
    • +2 more
    • (no location specified)
    Jun 9, 2023

    Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jul 6, 2022

    Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

    Not yet recruiting
    • Severe Aplastic Anemia
    • (no location specified)
    Oct 1, 2023

    Adding Azathioprine/Hydroxyurea Preconditioning to

    Recruiting
    • Sickle Cell Disease
    • Preconditioning with azathiprine and hydroxyurea (3 months)
    • Amsterdam, Netherlands
      Amsterdam Medical Centre
    Feb 9, 2022

    Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)

    Recruiting
    • Sickle Cell Disease
    • Hematopoietic stem cell transplantation
    • Duarte, California
      City of Hope Medical Center
    Jun 14, 2022

    Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

    Recruiting
    • Hemoglobinopathy (Disorder)
    • +2 more
    • Haploidentical Hematopoietic Cell Transplantation
    • Saint Petersburg, Florida
      Johns Hopkins All Children's Hospital
    Sep 13, 2022

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

    Not yet recruiting
    • Sickle Cell Disease
    • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 4, 2023

    Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

    Not yet recruiting
    • Recurrent Severe Aplastic Anemia
    • Refractory Severe Aplastic Anemia
    • Anti-Thymocyte Globulin
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Feb 23, 2023

    Waning Donor Chimerism, Waning Immune Function, Primary Immunodeficiency Disease(s) Trial in Cincinnati (CD34+)

    Terminated
    Has Results
    • Waning Donor Chimerism
    • +3 more
    • CD34+
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Nov 7, 2019

    End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,

    Not yet recruiting
    • End Stage Kidney Disease
    • +3 more
    • Donor CD34+, CD3+. and belumosudil
    • Los Angeles, California
      University of California, Los Angeles
    Apr 6, 2023

    AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

    Not yet recruiting
    • AML
    • +5 more
    • Infusion of CD34 selected hematopoietic stem cells
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 14, 2023

    Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

    Recruiting
    • Non-Malignant Neoplasm
    • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 29, 2022